Cefazolin

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Older cephalosporin.

Half-lifeThis section has been translated automatically.

1,4–2 h

Spectrum of actionThis section has been translated automatically.

Citrobacter diversus, Corynebacterium diphtheriae, Erysopelothrix rhusiopathiae, E. coli, Klebsiella spp., Moraxella catarrhalis, Neisseria spp., Proteus mirabilis, Salmonella spp.

IndicationThis section has been translated automatically.

Respiratory, urinary tract, skin, soft tissue and wound infections caused by gram-positive pathogens (except listeria), gonorrhoea.

Dosage and method of useThis section has been translated automatically.

  • Adults/children > 1 year: 2-3 g/day in 2-3 ED i.v.
  • Children after the 1st month of life: 25-50 mg/kg bw/day.
  • children after the 1st year of life: 50-100 mg/kg bw/day.

PreparationsThis section has been translated automatically.

Cefazolin, Elzogram

Note(s)This section has been translated automatically.

Cephalosporin is the most effective against staphylococci.

LiteratureThis section has been translated automatically.

  1. Stryjewski ME et al (2007) Use of vancomycin or first-generation cephalosporins for the treatment of hemodialysis-dependent patients with methicillin-susceptible Staphylococcus aureus bacteremia. Clin Infect Dis 44: 190-196

Authors

Last updated on: 29.10.2020

Author: Prof. Dr. med. Peter Altmeyer